Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study

Eitemau Tebyg

• A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
  gan: Hobart, Mary, et al.
  Cyhoeddwyd: (2019)
• A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia
  gan: Forbes, Andy, et al.
  Cyhoeddwyd: (2018)
• Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale
  gan: Hobart, Mary, et al.
  Cyhoeddwyd: (2018)
• Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
  gan: Davis, Lori L., et al.
  Cyhoeddwyd: (2016)
• Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
  gan: Berman, Robert M, et al.
  Cyhoeddwyd: (2011)